Exicure, Inc. XCUR
Set alert
1.01 USD +0.04 +4.30%
At close · Oct 30
1.03 +0.02 +1.55%
After hours · Oct 30, 5:58 PM ET
0.9438 Day range 1.06
0.935 52-week range 7.29
- YTD
- -81.37%
- 1 year
- -77.25%
- Open
- 0.9438
- Prev close
- 0.9684
- Mkt cap
- 6.61M
- Vol
- 29.57K
- Avg vol
- 45.27K
- EPS
- -1.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.9438
- High
- 1.06
- Forward P/E
- -25.38
- Beta
- 1.28
- Short ratio
- 0.19
- Inst. own
- 4.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 16, 2024
- 50-d avg
- 10.48
- 200-d avg
- 4.42
- 1y target
- 0.00
2Y chart
Signals (67)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 29, 2026 | 3 days ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 12, 2026 | 2 months ago |
| RSI: Oversold | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| RSI: Oversold | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 20, 2026 | 3 months ago |
| RSI: Oversold | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| RSI: Oversold | Jun 16, 2026 | 4 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| RSI: Oversold | May 15, 2026 | 5 months ago |
| MACD: Sell Signal | May 13, 2026 | 5 months ago |
| MACD: Buy Signal | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 20, 2026 | 7 months ago |
| SMA: Bullish | Mar 19, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 26, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 16, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 22, 2025 | 10 months ago |
| RSI: Overbought | Dec 4, 2025 | 11 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bearish | Nov 20, 2025 | 11 months ago |
| SMA: Bullish | Nov 19, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 19, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 9, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 22, 2025 | 1 year ago |
| RSI: Oversold | Sep 22, 2025 | 1 year ago |
| RSI: Oversold | Sep 3, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 14, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 22, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 7, 2025 | 1 year ago |
| RSI: Oversold | Jun 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| MACD: Buy Signal | May 21, 2025 | 1 year ago |
| MACD: Sell Signal | May 16, 2025 | 1 year ago |
| MACD: Buy Signal | May 8, 2025 | 1 year ago |
| SMA: Bearish | Apr 23, 2025 | 1 year ago |
| SMA: Bearish | Apr 17, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 2, 2025 | 1 year ago |
| SMA: Bullish | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 6, 2025 | 1 year ago |
| SMA: Bearish | Mar 5, 2025 | 1 year ago |
| SMA: Bullish | Mar 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 3, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 24, 2025 | 1 year ago |
Key statistics
- Market cap
- 59.38M
- Enterprise value
- 11.80M
- Trailing P/E
- 0.00
- Forward P/E
- -25.38
- PEG ratio
- 0.00
- Price / sales
- 118.77
- Price / book
- 11.15
- EPS (TTM)
- -2.02
- Beta
- 1.28
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 500.00K
- Revenue growth
- 0.00%
- Free cash flow
- -2.03M
- Total cash
- 528.00K
- Total debt
- 7.32M
- Return on equity
- -144.41%
- Shares outstanding
- 3.04M
- Short % of float
- 1.99%
- 50-day average
- 10.48
- 200-day average
- 4.42
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
May 16, 2024
Expected May 16, 2024. Consensus EPS estimate 0.00.
Financials — quick view
XCUR Revenue — quarterly 0
XCUR Net income — quarterly -1.12M
XCUR EPS — quarterly -0.18
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.35 | — | — |
| Jun 17, 2024 | Mar 1, 2024 | 0.00 | -0.50 | — | — |
| Jun 6, 2024 | Dec 1, 2023 | 0.00 | -0.65 | — | — |
| May 16, 2024 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 11, 2023 | Jun 1, 2023 | 0.00 | -3.40 | — | — |
| Jul 14, 2023 | Mar 1, 2023 | 0.00 | -3.50 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 16, 2022 | Chardan Capital | main | — | Neutral |
About Exicure, Inc.
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- exicuretx.com
News
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Comparing Shattuck Labs (NASDAQ:STTK) & Exicure (NASDAQ:XCUR)
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Exicure Receives Nasdaq Extension Through December 2 To Regain Compliance
- Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders' Equity Requirement
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Exicure Plans To Issue 172,058 Common Shares To GPCR Therapeutics During This Month To Settle $1M Clinical Milestone Payment Obligation
- Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance
- 12 Health Care Stocks Moving In Monday's Intraday Session
Your note
Sign in to keep a note on XCUR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CBI USA, INC. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 14, 2022 | 4,218,300 |
| DGP CO., LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 28, 2024 | 0 |
| FELTNER DOUGLAS E | Officer | Stock Award(Grant) | Nov 14, 2021 | 15,000 |
| GATES VENTURES, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 20, 2021 | 5,064,700 |
| GILJOHANN DAVID A. | Chief Executive Officer | Stock Award(Grant) | Nov 14, 2021 | 38,666 |
| MIRKIN CHAD A | Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 11, 2020 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Carlyle Group Inc. | 2.16% | 56,328 | 1.10M | Sep 29, 2024 |
| HRT Financial LP | 0.56% | 14,480 | 282.94K | Sep 29, 2024 |
| Northwestern University | 0.40% | 10,430 | 203.80K | Sep 29, 2024 |
| UBS Group AG | 0.37% | 9,588 | 187.35K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.05% | 1,414 | 27.63K | Sep 29, 2024 |
| Morgan Stanley | 0.02% | 645 | 12.60K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.31% | 8,019 | 156.69K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.16% | 4,167 | 81.42K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 1,527 | 29.84K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.03% | 896 | 17.51K | Oct 30, 2024 |
| Master Investment Portfolio-Diversified Equity Master Portfolio | 0.00% | 35 | 683 | Sep 29, 2024 |